Direct oral anticoagulants
63 results
1 - 63
Direct oral anticoagulants - Direct oral anticoagulants versus warfarin among atrial fibrillation patients with chronic kidney disease
- Direct oral anticoagulants versus vitamin K antangonists in non-valvular atrial fibrillation
- Mitral regurgitation
- Aortic stenosis
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis
- Antithrombotic agents in primary health care
- Deep vein thrombosis
- Oral anticoagulation for prolonging survival in patients with cancer
- Prevention of venous thromboembolism
- Heart valve operation: patient follow-up and complications
- Anticoagulant therapy in acute (duration less than 48 hours) atrial fibrillation - Image
- Tranexamic acid in people on anticoagulants undergoing minor oral surgery or dental extractions
- Nephrotic syndrome
- Warfarin therapy
- Vitamin K for improved anticoagulation control in patients receiving warfarin
- Superficial venous thrombophlebitis
- Management of acute atrial fibrillation
- Electrical cardioversion
- Systemic lupus erythematosus (SLE)
- Acute coronary syndrome
- Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
- Transient ischaemic attack (TIA)
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
- Assessment and treatment of a patient with bleeding diathesis
- Lumbar puncture
- Cerebral infarction (ischaemic stroke)
- COVID-19 and other coronavirus infections
- Antiplatelet therapy for prevention of death, myocardial infarction, and stroke